CLCezary Lubas

Cezary Lubas

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Cezary Lubas has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    METHODS OF TREATMENT FOR STRESS URINARY INCONTINENCE (SUI): A REVIEW OF CURRENT RESEARCH

    by Antoni Kujawski, Anna Opalińska, Cezary Lubas, Paula Folta, Joanna Kłosowska, Karolina Błądzińska, Maciej Błądziński, Dominika Machała, Piotr Świerczek, Kacper Szeląg

    Research objectives: This study aims to provide a comprehensive analysis of treatments for Stress Urinary Incontinence (SUI). Through a detailed discussion and review of the evidence, we examine conservative, pharmacological, and surgical approaches, highlighting their therapeutic benefits. This review also synthesizes the current literature to summarize the advantages and limitations of each method in relation to specific patient groups. Methods: A literature search was conducted in PubMed and Google Scholar, with emphasis on publications from 2015-2025. The search strategy included terms such as ‘stress urinary incontinence’, ‘pessary’, ‘surgical intervention’, and ‘treatment choice’. Key findings and conclusions: Stress urinary incontinence (SUI) is a common condition affecting women across a wide range of ages. Effective management requires an individualized approach in which the therapeutic method is selected based on the severity of symptoms, the patient’s anatomical characteristics, coexisting chronic diseases, reproductive plans, and personal expectations regarding treatment outcomes. First-line therapy for SUI consists of conservative methods, including pelvic floor muscle training, behavioral modification, weight reduction, pessary use, and topical estrogen therapy in postmenopausal women. Although the benefits of duloxetine have been demonstrated, its clinical utility is limited by adverse effects and contraindications during pregnancy, resulting in a restricted role for pharmacotherapy in SUI management. When conservative treatment fails to provide adequate improvement, surgical intervention should be considered. Current evidence supports the mid-urethral sling (MUS) as the preferred surgical method due to its long-term effectiveness and favorable safety profile. MUS has largely replaced earlier techniques such as Burch colposuspension, although the latter may still offer advantages in selected patient groups. In summary, the treatment of SUI encompasses a wide range of therapeutic options, each with distinct benefits and limitations. Therefore, shared decision-making that incorporates the patient’s medical characteristics and individual preferences is crucial for achieving optimal treatment outcomes.

  • Open Access

    NOVEL APPROACHES IN OBESITY TREATMENT: THE PROMISE OF GENE THERAPIES

    by Karolina Błądzińska, Anna Opalińska, Cezary Lubas, Paula Folta, Kacper Szeląg, Joanna Kłosowska, Maciej Błądziński, Małgorzata Zach, Piotr Świerczek, Antoni Kujawski

    Introduction and Purpose: Obesity constitutes a significant global public health concern driven by multifactorial interactions among genetic, metabolic, and environmental determinants [2, 7, 13, 28]. Conventional interventions—including lifestyle modification, pharmacotherapy, and bariatric procedures—frequently provide only limited or temporary benefits [2, 21]. This review evaluates emerging gene-based therapeutic strategies designed to target the molecular pathways responsible for obesity development and progression. Current State of Knowledge: Preclinical animal studies utilizing adeno-associated virus (AAV) vectors have demonstrated effective adipose-tissue-specific gene delivery, resulting in enhanced thermogenesis, improved insulin sensitivity, and measurable reductions in adiposity [8, 10, 12, 16, 26]. Key metabolic regulators, such as fibroblast growth factor 21 (FGF21), uncoupling protein 1 (UCP1), and elements of the leptin–melanocortin axis, have shown promising modulation in experimental models [4, 8, 9, 22,32]. Furthermore, adipose-derived mesenchymal stem cells are being explored as potential vehicles for targeted gene delivery, although these approaches remain in early developmental phases [14]. Clinically, the most advanced gene-based interventions include RNA interference (RNAi) platforms—particularly modulators of pathways such as ALK7 or INHBE—which are currently undergoing evaluation for obesity management [ 23, 31]. Summary: While gene therapy applications for obesity remain primarily experimental, emerging evidence underscores their potential to address fundamental metabolic dysfunction rather than merely mitigate clinical manifestations [8, 18, 24]. Advancements in vector precision, tissue-targeted delivery, and long-term safety evaluation will be essential for future translation into clinical practice [10, 11, 26]

  • Open Access

    BENEFITS OF SOCIAL DANCING AMONG OLDER ADULTS WITH COGNITIVE DECLINE AND NEURODEGENERATIVE DISEASES: A SYSTEMATIC REVIEW

    by Anna Opalińska, Paula Folta, Cezary Lubas, Joanna Kłosowska, Kacper Szeląg, Karolina Błądzińska, Maciej Błądziński, Małgorzata Zach, Piotr Świerczek, Antoni Kujawski

    Research objectives: This review aims to synthesize the current evidence on social dancing for older adults, with particular emphasis on its therapeutic benefits for individuals with Parkinson’s disease. Methods: A literature review was gathered using PubMed and Google Scholar, emphasizing papers published in the last five years. The search included the keywords ‘dance’, ‘cognitive function’, and ‘physical activity’. Key findings and conclusions: The expansion and ongoing advancement of modern medicine correlates with the increase in the older adult population. As a result, cognitive decline has become one of the major health problems associated with advanced age. Nearly 50% of individuals over 85 years are suffering from dementia and related neurodegenerative diseases. Extending healthy life expectancy has become a cardinal priority for public-health systems and biomedical research alike. Despite ongoing efforts, the search for low-cost, scalable interventions that can simultaneously preserve neural function, functional mobility, and psychosocial well-being remains incomplete. Studies show that dance-based exercise is a promising candidate. Accumulated findings indicate that dance constitutes a biologically and psychosocially potent intervention, simultaneously enhancing cardiovascular efficiency, maintaining neuromuscular integrity, promoting neuroplastic remodelling, and improving emotional well-being.

  • Open Access

    PROPOLIS SUPPLEMENTATION - EFFECTS ON PHYSICAL ACTIVITY, SKIN, BONE HEALTH, AND CARDIOVASCULAR FUNCTION: A SYSTEMATIC REVIEW

    by Paula Folta, Anna Opalińska, Cezary Lubas, Joanna Kłosowska, Kacper Szeląg, Karolina Błądzińska, Maciej Błądziński, Małgorzata Zach, Piotr Świerczek, Antoni Kujawski

    Introduction: In recent years, many sports supplements have incorporated several natural ingredients. One notable example is propolis, a bee-derived substance rich in bioactive compounds such as flavonoids, phenolic acids, and vitamins. Research indicates that bee glue has several therapeutic properties, including anti-inflammatory, antioxidant, and immunomodulatory effects. These mechanisms support wound healing, strengthen the immune system, combat respiratory infections, improve both recovery and physical capacity, all of which may collectively lead to enhanced athletic performance. Aim of the study: This study aims to provide a comprehensive analysis of propolis properties. Through a detailed discussion and review of the evidence supporting the beneficial effects of propolis supplementation on the skin, as well as the muscular, skeletal, and cardiovascular systems. Material and method: This article presents the current state of knowledge about the effects of propolis supplementation. A literature review was gathered using PubMed, ScienceDirect, and Google Scholar platforms, with a focus on papers from the last five years. The search included the keywords ‘propolis’, ‘antioxidant activity’, ‘anti-inflammatory’, ‘exercise’, ‘skin regeneration’, and ‘cardiovascular function’. Results: Literature review revealed that propolis emerges as a multi-target phytocomplex that attenuates inflammation, augments antioxidant defenses, and favorably modulates vascular and musculoskeletal function across pre-clinical models. Synergistic effects with exercise, biomaterial carriers, and microbiota-directed strategies underscore opportunities for combination interventions.


  • Open Access

    THE EFFECT OF FENOFIBRATE ON THE DEVELOPMENT OF DIABETIC RETINOPATHY AND NEPHROPATHY – A REVIEW OF CURRENT RESEARCH

    by Kacper Szeląg, Anna Opalińska, Cezary Lubas, Paula Folta, Joanna Kłosowska, Karolina Błądzińska, Maciej Błądziński, Małgorzata Zach, Piotr Świerczek, Antoni Kujawski

    The aim of this review is to summarize current knowledge on the effect of fenofibrate in reducing the risk and progression of two major diabetes complications: retinopathy and kidney disease. We also discuss the mechanisms underlying fenofibrate’s potential protective effects and the pathophysiology of these complications. A literature search was conducted in PubMed and Google Scholar, with emphasis on publications from 2020–2025. The search strategy included terms such as “fenofibrate diabetes,” “fenofibrate nephropathy,” “fenofibrate retinopathy,” “diabetic kidney disease,” and “diabetes dyslipidemia.” Diabetes mellitus affects over 537 million people worldwide, reducing quality of life and creating a major healthcare burden. Fenofibrate, a fibrate-class lipid-lowering agent, has gained attention due to its frequent use in patients with diabetes and dyslipidemia. Evidence suggests that fenofibrate may slow the progression of diabetic retinopathy, reducing the need for surgical interventions, and may also decrease albuminuria and delay the progression of diabetic kidney disease. In conclusion, fenofibrate appears to have potential as an adjunct therapy for preventing microvascular complications of diabetes, although further research is required to confirm its long-term benefits.

  • Open Access

    OCULAR TRAUMA: A LITERATURE REVIEW OF CLASSIFICATION, EPIDEMIOLOGY, AND MANAGEMENT

    by Małgorzata Zach, Joanna Kłosowska, Karolina Błądzińska, Maciej Błądziński, Piotr Świerczek, Paula Folta, Dominika Machała, Kamila Machała, Anna Opalińska, Cezary Lubas

    Introduction and purpose: Ocular trauma is a major global cause of visual impairment, accounting for an estimated 1.6 million cases of blindness annually. It presents significant clinical and socioeconomic challenges. This review provides an overview of the classification, epidemiology, causes, prevention and management of ocular trauma. State of knowledge: Eye injuries are broadly categorized into open-globe and closed-globe injuries, with further classification based on mechanism, anatomical zone and visual acuity. The Ocular Trauma Score (OTS) is a commonly employed prognostic tool, although its predictive accuracy has limitations. Ocular trauma disproportionately affects men and working-age individuals. Occupational and sports-related injuries are highly prevalent, and up to 90% are considered preventable with use of personal protective equipment. Prompt diagnosis and tailored management, including immediate irrigation for chemical injuries and urgent surgical intervention for open-globe trauma, are essential for optimal visual outcomes. Conclusions: Effective management of eye injuries relies on accurate classification and timely intervention. Standardized tools and education can improve outcomes, while public health efforts must prioritize prevention and access to care to reduce the global burden of ocular trauma. Materials and methods: A review of literature was conducted using Google Scholar and PubMed databases, focusing on articles published between 2020 and 2025.

  • Open Access

    ASSOCIATION BETWEEN CONNECTIVE TISSUE DISORDERS AND LUMBAR DISC HERNIATION: A SYSTEMATIC REVIEW

    by Maciej Błądziński, Karolina Błądzińska, Joanna Kłosowska, Anna Opalińska, Cezary Lubas, Paula Folta, Kacper Szeląg, Małgorzata Zach, Piotr Świerczek, Antoni Kujawski

    Lumbar disc herniation (LDH) is one of the most common structural causes of low back pain worldwide. While mechanical overload and age-related degeneration are widely recognized as key factors, recent research suggests that connective tissue disorders (CTDs) and related genetic abnormalities may also play a significant role in disc pathology. This systematic review aimed to evaluate the current evidence on the relationship between CTDs and LDH from clinical, genetic, and mechanistic perspectives. A comprehensive literature search was performed in PubMed and Google Scholar up to April 2025, according to PRISMA guidelines. Thirteen studies were included, encompassing genome-wide association studies, cohort and case-control studies, experimental animal models, and proteomic analyses. Several genetic variants related to extracellular matrix components and sulfate transport, including CHST3, ADAMTS17, and COL11A2, were found to be associated with lumbar disc degeneration. Clinical studies showed a potential link between joint hypermobility or rheumatoid arthritis and higher LDH prevalence or postoperative complications, although findings were inconsistent. Mechanistic models highlighted local molecular changes, such as altered TGF-β signaling and overexpression of CILP or AEBP1, which may impair disc integrity. Despite growing molecular insights, the clinical correlation between CTDs and LDH remains insufficiently explored. More longitudinal studies with standardized definitions of CTDs and better genetic profiling are necessary to clarify these associations and improve patient stratification.

  • Open Access

    TREATMENT OF MINIMAL CHANGE DISEASE IN ADULTS: CURRENT PRACTICE AND FUTURE DIRECTIONS – A NARRATIVE LITERATURE REVIEW

    by Cezary Lubas, Joanna Kłosowska, Piotr Świerczek, Małgorzata Zach, Karolina Błądzińska, Maciej Błądziński, Kacper Szeląg, Antoni Kujawski, Paula Folta, Anna Opalińska

    Research Objectives: This review aims to summarize the current therapeutic strategies for adults with MCD and to discuss future treatment directions in light of emerging immunological and molecular findings. Methods: Literature was searched using PubMed and Google Scholar, with a focus on studies from the past five years. Keywords used in the search included: „minimal change disease”, „nephrotic syndrome”, „glucocorticoids”, „rituximab”, „TRPC6”, and „adults”. Key Findings: Minimal change disease (MCD) is the most common cause of nephrotic syndrome in children and a significant contributor in adults. Although its clinical course in adults is often mild and steroid-responsive, many patients experience relapses, steroid resistance, or develop adverse effects related to prolonged glucocorticoid use. Glucocorticoids remain the first-line therapy for MCD, achieving remission in approximately 90% of adults, but relapses affect more than half of these patients. Alternative immunosuppressive therapies have shown comparable efficacy in inducing remission and may lower the relapse rate. Rituximab has shown significant therapeutic efficacy in steroid-dependent and frequently relapsing cases. Several new pharmacological agents - including TRPC6 inhibitors and ManNAc - are under investigation. Immunomodulatory therapies targeting B and T cells also show promise and are being explored in early-phase studies. Conclusions: MCD presents ongoing therapeutic challenges due to steroid-related toxicity, and heterogeneous treatment responses. A deeper understanding of the disease’s immunopathogenesis is opening new avenues for targeted and safer therapies. Further studies are needed to optimize treatment protocols and improve long-term prognosis and quality of life.

  • Open Access

    A REVIEW OF THE EFFECTS OF FENUGREEK (TRIGONELLA FOENUM-GRAECUM L.) SUPPLEMENTATION ON ENDOCRINE FUNCTION, SEXUAL HEALTH, AND MUSCLE PERFORMANCE IN ADULTS

    by Piotr Świerczek, Joanna Kłosowska, Małgorzata Zach, Karolina Błądzińska, Maciej Błądziński, Kamila Machała, Antoni Kujawski, Paula Folta, Anna Opalińska, Cezary Lubas

    Research objectives: The purpose of this review is to present scientific evidence on the effects of fenugreek seed extract on sex hormone concentrations, sexual function, functional and morphological parameters of skeletal muscle in adults, and to summarize data on the safety of its supplementation. Methods: A literature review was conducted using PubMed and Google Scholar with a focus on papers from the last ten years. The research included keywords: Trigonella foenum-graecum, fenugreek, testosterone, safety, libido, skeletal muscles Key findings and conclusions: Fenugreek (Trigonella foenum-graecum L.) is a plant from the Fabaceae family that has been used for centuries in traditional Indian medicine, particularly within Ayurveda. It is reported to have a range of health-promoting properties, including stimulating appetite and lactation, enhancing libido, and alleviating menopausal symptoms. Some studies also suggest that it may help regulate blood glucose levels in individuals with type 2 diabetes, lower cholesterol levels, and improve sexual function in men. Fenugreek seeds are rich in bioactive compounds such as alkaloids, steroidal saponins, flavonoids, and 4-hydroxyisoleucine. Among these, saponins—especially diosgenin and yamogenin, which make up approximately 4.8% of the seed content—are considered particularly important due to their estrogenic and androgenic activity. While fenugreek supplementation may offer various health benefits, some sources also point to potential adverse effects, including possible toxicities resulting from improper or excessive use of fenugreek-based products.

  • Open Access

    VEXAS SYNDROME – A NEW CHALLENGE AT THE INTERFACE OF RHEUMATOLOGY AND HEMATOLOGY: A REVIEW PAPER

    by Joanna Kłosowska, Piotr Świerczek, Małgorzata Zach, Karolina Błądzińska, Maciej Błądziński, Kacper Szeląg, Antoni Kujawski, Paula Folta, Anna Opalińska, Cezary Lubas

    Research Objectives: This review summarizes current knowledge on VEXAS syndrome—its genetics, pathophysiology, symptoms, diagnosis, treatment, and prognosis—highlighting its clinical relevance. Methods: A focused literature review was conducted using PubMed and Google Scholar, emphasizing recent studies and relevant keywords related to VEXAS syndrome. Key Findings: VEXAS syndrome (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic) is a newly identified, rare autoinflammatory disease caused by a somatic mutation in the UBA1 gene. It occurs almost exclusively in men and combines treatment-resistant inflammatory symptoms with bone marrow dysplasia, posing diagnostic and therapeutic challenges. VEXAS has a non-specific clinical course, combining symptoms of autoinflammatory diseases (e.g., chondritis, fever, vasculitis) with hematologic features such as cytopenias, macrocytosis, and myelodysplastic syndromes (MDS). Diagnosis is often delayed and requires high clinical suspicion and genetic testing of bone marrow to detect UBA1 mutations. There are no standardized treatment protocols; therapy usually includes glucocorticosteroids, immunosuppressants, and targeted agents. Allogeneic bone marrow transplantation may be an option in selected patients. Conclusions: VEXAS syndrome lies at the intersection of rheumatology and hematology. Though recently discovered, its clinical importance is growing. Diagnosis demands a multidisciplinary approach and molecular testing. Further studies and patient registries are essential to improve care and understanding of the disease.